BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25733984)

  • 1. Predicting amyloid status in corticobasal syndrome using modified clinical criteria, magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
    Sha SJ; Ghosh PM; Lee SE; Corbetta-Rastelli C; Jagust WJ; Kornak J; Rankin KP; Grinberg LT; Vinters HV; Mendez MF; Dickson DW; Seeley WW; Gorno-Tempini M; Kramer J; Miller BL; Boxer AL; Rabinovici GD
    Alzheimers Res Ther; 2015; 7(1):8. PubMed ID: 25733984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET Patterns Predict Amyloid Deposition and Clinical Profile in Corticobasal Syndrome.
    Parmera JB; Coutinho AM; Aranha MR; Studart-Neto A; de Godoi Carneiro C; de Almeida IJ; Fontoura Solla DJ; Ono CR; Barbosa ER; Nitrini R; Buchpiguel CA; Brucki SMD
    Mov Disord; 2021 Mar; 36(3):651-661. PubMed ID: 33206389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study.
    Parmera JB; de Almeida IJ; de Oliveira MCB; Silagi ML; de Godoi Carneiro C; Studart-Neto A; Ono CR; Reis Barbosa E; Nitrini R; Buchpiguel CA; Brucki SMD; Coutinho AM
    Front Neurol; 2021; 12():702052. PubMed ID: 34526958
    [No Abstract]   [Full Text] [Related]  

  • 4. Probable 4-Repeat Tauopathy Criteria Predict Brain Amyloid Negativity, Distinct Clinical Features, and FDG-PET/MRI Neurodegeneneration Patterns in Corticobasal Syndrome.
    Parmera JB; de Godoi Carneiro C; de Almeida IJ; de Oliveira MCB; Barbosa PM; Studart-Neto A; Ono CR; Nitrini R; Buchpiguel CA; Barbosa ER; Brucki SMD; Coutinho AM
    Mov Disord Clin Pract; 2024 Mar; 11(3):238-247. PubMed ID: 38155526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.
    Rabinovici GD; Rosen HJ; Alkalay A; Kornak J; Furst AJ; Agarwal N; Mormino EC; O'Neil JP; Janabi M; Karydas A; Growdon ME; Jang JY; Huang EJ; Dearmond SJ; Trojanowski JQ; Grinberg LT; Gorno-Tempini ML; Seeley WW; Miller BL; Jagust WJ
    Neurology; 2011 Dec; 77(23):2034-42. PubMed ID: 22131541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
    Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
    Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of PiB-positive corticobasal syndrome.
    Burrell JR; Hornberger M; Villemagne VL; Rowe CC; Hodges JR
    PLoS One; 2013; 8(4):e61025. PubMed ID: 23577184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-based classification of corticobasal syndrome.
    Nakano Y; Shimada H; Shinotoh H; Hirano S; Tagai K; Sano Y; Yamamoto Y; Endo H; Matsuoka K; Takahata K; Kubota M; Takado Y; Kimura Y; Ichise M; Ono M; Sahara N; Kawamura K; Zhang MR; Kuwabara S; Suhara T; Higuchi M
    Parkinsonism Relat Disord; 2022 May; 98():92-98. PubMed ID: 35533530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Ali F; Whitwell JL; Martin PR; Senjem ML; Knopman DS; Jack CR; Lowe VJ; Petersen RC; Boeve BF; Josephs KA
    J Neurol; 2018 May; 265(5):1079-1088. PubMed ID: 29497818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroimaging in corticobasal syndrome].
    Shinotoh H
    Rinsho Shinkeigaku; 2013; 53(11):1029-32. PubMed ID: 24291869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual Brain Metabolic Signatures in Corticobasal Syndrome.
    Cerami C; Dodich A; Iannaccone S; Magnani G; Marcone A; Guglielmo P; Vanoli G; Cappa SF; Perani D
    J Alzheimers Dis; 2020; 76(2):517-528. PubMed ID: 32538847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroimaging in corticobasal syndrome].
    Shinotoh H; Hirano S
    Brain Nerve; 2013 Jan; 65(1):41-53. PubMed ID: 23300102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of Pittsburgh compound-B-negative dementia.
    Takeuchi J; Shimada H; Ataka S; Kawabe J; Mori H; Mizuno K; Wada Y; Shiomi S; Watanabe Y; Miki T
    Dement Geriatr Cogn Disord; 2012; 34(2):112-20. PubMed ID: 22947919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P; Carter SF; Rinne JO; Gelosa G; Herholz K; Nordberg A; Brooks DJ; Hinz R
    Neuroimage; 2013 Apr; 70():423-33. PubMed ID: 23261639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.
    Klupp E; Grimmer T; Tahmasian M; Sorg C; Yakushev I; Yousefi BH; Drzezga A; Förster S
    J Nucl Med; 2015 Mar; 56(3):399-404. PubMed ID: 25678488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid in dementia associated with familial FTLD: not an innocent bystander.
    Naasan G; Rabinovici GD; Ghosh P; Elofson JD; Miller BL; Coppola G; Karydas A; Fong J; Perry D; Lee SE; Yokoyama JS; Seeley WW; Kramer JH; Weiner MW; Schuff N; Jagust WJ; Grinberg LT; Pribadi M; Yang Z; Sears R; Klein E; Wojta K; Rosen HJ
    Neurocase; 2016; 22(1):76-83. PubMed ID: 26040468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.